Article
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
Cancer research - 1 May 2016
Kadariya Yuwaraj, Cheung Mitchell, Xu Jinfei, Pei Jianming, Sementino Eleonora, Menges Craig W, Cai Kathy Q, Rauscher Frank J, Klein-Szanto Andres J, Testa Joseph R
Abstract excerpt
Individuals harboring inherited heterozygous germline mutations in BAP1 are predisposed to a range of benign and malignant tumor types, including malignant mesothelioma, melanoma, and kidney carcinoma. However, evidence to support a tumor-suppressive role for BAP1 in cancer remains contradictory. To test experimentally whether BAP1 behaves as a tumor suppressor, we monitored spontaneous tumor development in three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
